ReCode Therapeutics, Inc.
5Patents
5Active
5Granted
59Portfolio score
Filing activity: May 3, 2023 → Sep 16, 2024
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US12133923B2 | Lipid nanoparticle compositions and uses thereof | Chemistry; Metallurgy | 1 | Active |
| US12257318B2 | Polynucleotide compositions, related formulations, and methods of use thereof | Chemistry; Metallurgy | 0 | Active |
| US12121610B2 | Compositions and methods for targeted delivery to cells | Chemistry; Metallurgy | 0 | Active |
| US12337068B2 | Lipid nanoparticle compositions and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US12364773B2 | Lipid nanoparticle compositions and uses thereof | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.